Cargando…
Efficacy and Safety of Nilutamide in Patients with Metastatic Prostate Cancer Who Underwent Orchiectomy: A Systematic Review and Meta-analysis
BACKGROUND: Prostate cancer is the sixth leading cause of death, among all cancer deaths By 2030, this burden is expected to increase with 1.7 million new cases and 499,000 new deaths. We aimed to evaluate the efficacy and safety of Nilutamide in metastatic prostate cancer (mPCa) patients who underw...
Autores principales: | Rashid, Muhammed, Shamshavali, K., Chhabra, Manik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040499/ https://www.ncbi.nlm.nih.gov/pubmed/30648519 http://dx.doi.org/10.2174/1574884714666190112151202 |
Ejemplares similares
-
Nilutamide
por: Trasi, Niraj S., et al.
Publicado: (2012) -
Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies
por: Chhabra, Manik, et al.
Publicado: (2022) -
Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?
por: Decensi, A., et al.
Publicado: (1994) -
Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomy
por: Sarkar, Arjun, et al.
Publicado: (2021) -
Partial orchiectomy vs. radical orchiectomy for pediatric testis tumors
por: Woo, Lynn L., et al.
Publicado: (2020)